Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.

Gurm, Hitinder S

Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. [electronic resource] - Journal of the American College of Cardiology Jun 2005 - 1932-8 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0735-1097

10.1016/j.jacc.2005.02.074 doi


Aged
Angioplasty, Balloon, Coronary
Anticoagulants--therapeutic use
Coronary Artery Disease--etiology
Diabetes Mellitus, Type 2--complications
Double-Blind Method
Female
Heparin--therapeutic use
Hirudins
Humans
Male
Middle Aged
Peptide Fragments--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Recombinant Proteins--therapeutic use
Treatment Outcome